Xiaohuan Li
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Increased plasma GPNMB levels in patients with parkinson's disease and cognitive impairment.
Journal: Scientific reports
Published: October 10, 2024
Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
Journal: Neurobiology of disease
Published: October 05, 2023
Diagnostic value of plasma SIRT1 levels and whole-brain gray matter volume in Parkinson's disease patients with cognitive impairment.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: July 18, 2023
Clinical findings of hyperechoic substantia nigra in patients with Parkinson's disease.
Journal: The European journal of neuroscience
Published: July 12, 2023
Increased plasma lipocalin-2 levels are associated with nonmotor symptoms and neuroimaging features in patients with Parkinson's disease.
Journal: Journal of neuroscience research
Published: May 19, 2023
Associations of blood UCH-L1 and NfL levels with cognitive dysfunction in Parkinson's disease patients.
Journal: Neuroscience letters
Published: February 09, 2023
Predictors of dopamine dysregulation syndrome in patients with early Parkinson's disease.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: January 18, 2023
miR-494-3p Promotes Erastin-Induced Ferroptosis by Targeting REST to Activate the Interplay between SP1 and ACSL4 in Parkinson's Disease.
Journal: Oxidative medicine and cellular longevity
Published: March 31, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026